Sunday, November 3, 2024
HomeTagsSolid Tumors

Solid Tumors

ArsenalBio Secures $325M to Propel Programmable Cell Therapies

Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close...

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8...

Thermo Fisher Scientific and Arsenal Biosciences Form Collaboration to Support Clinical Manufacturing of Autologous T-Cell Therapies

Thermo Fisher Scientific, the global leader in serving science, and Arsenal Biosciences, Inc. , a cell therapy clinical development company, to develop novel chimeric...

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1

Ascletis Pharma Inc. announces the completion of first patient dosing in the U.S. Phase I clinical trial of ASC61, an oral PD-L1 small molecule...

Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics